Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
1 other identifier
observational
392
1 country
1
Brief Summary
Several studies have investigated an association between cardiac autonomic neuropathy (CAN) and albuminuria, glomerular filtration rate, or both, and hypothesized that CAN is involved in the pathogenesis of nephropathy. However, most of these studies had focused on Caucasians and were limited to a small number of patients with type 1 diabetes mellitus, or had used a conventional Ewing battery of tests based on dynamic cardiovascular maneuvers.Yet, there is consistent data showing that Asian diabetic populations, including the Chinese, have a higher risk of renal complications than Caucasians do. The present study investigated an association between heart rate variability (HRV) parameters and diabetic kidney disease (DKD) in Chinese type 2 diabetes mellitus (T2DM) patients, specifically through time and frequency domain analyses of HRV and urine albumin creatinine ratio (UACR) or estimated glomerular filtration rate (eGFR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 24, 2016
CompletedFirst Posted
Study publicly available on registry
December 19, 2016
CompletedDecember 19, 2016
December 1, 2016
2.2 years
November 24, 2016
December 14, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Association between HRV and renal function (eGFR and UACR)
Assessment of HRV HRV measurement based on 24-hour ambulatory ECG monitoring was obtained from all patients using a 3- channel digital Holter recorder (CB-2302-A, Wuxi, Jiangsu, China). Assessment of DKD DKD was defined as the presence of albuminuria (UACR ≥ 30 mg/g,urine albumin in milligram,creatinine in gram) or eGFR \< 60 mL/min/1.73 m\^2 (creatinine concentration in umol/l,creatinine molecular weight in micromole, volume in litre;urine volume per minute in milliliter per minute; body surface area in square meter) based on SCr levels. Albuminuria was defined using UACR of a single early-morning urine measurement.For all Participants, 132 patients had albuminuria and 50 patients with eGFR \< 60 mL/min/1.73 m\^2
1week
Secondary Outcomes (1)
Clinical characteristics of patients
1week
Study Arms (1)
Type 2 diabetes
With Clinical examination and laboratory measurements
Interventions
Subjects were interviewed by a physician regarding their medical history, history of hypoglycemic attacks, smoking status, and alcohol consumption. Concentrations of blood urea nitrogen (BUN) and serum creatinine (SCr) were analyzed by the urease-ultraviolet rate method and picric acid method, respectively. Serum uric acid was determined using the enzymatic colorimetric method. Serum hemoglobin A1c (HbA1c) was measured by liquid enzymatic assay. Urine albumin and urine creatinine were found through immune turbidimetric analysis and the enzymatic method, respectively.
Eligibility Criteria
392 patients of T2DM consecutively recruited from February 2013 to April 2015 in the inpatient department of Kunming First People's Hospital.The Institutional Review Board of Kunming First People's Hospital approved the study protocol. Adult patients with T2DM who had consecutively undergone 24-hour Holter monitoring for HRV analysis were included.
You may qualify if:
- Clinical diagnosis of T2DM
- Adult patients has had consecutively undergone 24-hour Holter monitoring for heart rate variability analysis
You may not qualify if:
- Patients with acute complications of DM including diabetic ketoacidosis, hyperosmolar coma
- Foot ulcer
- Severe acute or chronic infection
- Chronic liver disease
- Dialysis or renal transplantation
- The presence of any serious concomitant disease affecting life expectancy were not eligible for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shi wei, MMlead
Study Sites (1)
Internal medicine department, Kunming First People's Hospital
Kunming, Yunnan, 650000, China
Related Publications (1)
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.
PMID: 25249672BACKGROUND
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xiaolei Chen, MM
Kunming first people's hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
November 24, 2016
First Posted
December 19, 2016
Study Start
February 1, 2013
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
December 19, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will share
The basic records of patients